HIF-1α has been linked, in a recent study, to the development of chemotherapeutic resistance in cancer; consequently, cisplatin resistance may be reversed by targeting HIF-1α using RNA-interference or small interfering RNA. The gene discussed is HIF1A; the disease is cancer.